Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Regulatory News (ABDN)

Share Price Information for Abrdn (ABDN)

Share Price is delayed by 15 minutes
Get Live Data
236.60    2.60 (1.11%)
Bid:
238.40
Ask:
238.60
Spread: 0.20 (0.084%)
Market Cap: £4.23b
ABDN Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Share Chart

Form 8.3 DCC plc

Today 13:30

RNS Number : 2562J
Aberdeen Group PLC
22 June 2026
 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Aberdeen Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

DCC plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

19 June 2026

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

€0.25 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

882,506

1.03

(2) Cash-settled derivatives

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

Total

882,506

1.03

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

 €0.25 ordinary shares

Purchase

200,000

GBP 62.000

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

NO

 

Date of disclosure

22 June 2026

Contact name

Cara Bird

Telephone number

+44 1224 425 120

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

Ap31

 

NOTES ON FORM 8.3

 

1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. See Rule 2.5(d) of Part A of the Rules.

 

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPLLLFLQQLLBBK
Date   Source Headline
2nd Mar 202611:23 amRNSForm 8.3 - Senior plc
25th Feb 202611:46 amRNSForm 8.3 - Oxford Biomedica plc
25th Feb 202611:40 amRNSForm 8.3 - LondonMetric Property plc
25th Feb 202611:36 amRNSForm 8.3 - British Land Co PLC, The
24th Feb 20261:49 pmRNSForm 8.3 - LondonMetric Property plc
24th Feb 20261:45 pmRNSForm 8.3 - British Land Co PLC, The
18th Feb 202611:19 amRNSForm 8.3 - LondonMetric Property PLC
18th Feb 202611:14 amRNSForm 8.3 - British Land Co PLC, The
17th Feb 202610:54 amRNSForm 8.3 - LondonMetric Property plc
16th Feb 20261:29 pmRNSForm 8.3 - LondonMetric Property plc
16th Feb 20261:23 pmRNSForm 8.3 - British Land Co PLC, The
12th Feb 20261:20 pmRNSForm 8.3 - Oxford Biomedica plc
12th Feb 20261:17 pmRNSForm 8.3 - LondonMetric Property PLC
12th Feb 202611:50 amRNSForm 8.3 - International Personal Finance PLC
12th Feb 202611:45 amRNSForm 8.3 - British Land Co PLC, The
11th Feb 20269:58 amRNSForm 8.3 - British Land Co PLC, The
10th Feb 202611:31 amRNSForm 8.3 - British Land Co PLC, The
5th Feb 20261:52 pmRNSForm 8.3 Oxford Biomedica plc
3rd Feb 20261:48 pmRNSHolding(s) in Company
3rd Feb 202612:23 pmRNSForm 8.3 - Bluefield Solar Income Fund Limited
3rd Feb 202612:19 pmRNSForm 8.3 - Oxford Biomedica PLC
3rd Feb 202612:14 pmRNSForm 8.3 - International Personal Finance PLC
3rd Feb 202612:10 pmRNSForm 8.3 - British Land Co PLC, The
3rd Feb 202612:06 pmRNSForm 8.3 - Picton Property Income Limited
2nd Feb 202610:10 amRNSTotal Voting Rights
29th Jan 20261:39 pmRNSHolding(s) in Company
29th Jan 202612:19 pmRNSForm 8.3 - British Land Co PLC, The
29th Jan 202612:13 pmRNSForm 8.3 - Life Science REIT PLC
29th Jan 202612:04 pmRNSForm 8.3 - Auction Technology Group plc
28th Jan 20263:49 pmRNSHolding(s) in Company
28th Jan 202612:11 pmRNSForm 8.3 - Unite Group plc/The
28th Jan 202612:08 pmRNSForm 8.3 - Oxford Biomedica PLC
26th Jan 20261:25 pmRNSForm 8.3 - Unite Group plc, The
26th Jan 202612:01 pmRNSForm 8.3 - Picton Property Income Limited
26th Jan 202611:58 amRNSForm 8.3 - JTC plc
26th Jan 202611:53 amRNSForm 8.3 - International Personal Finance plc
22nd Jan 202610:55 amRNSForm 8.3 - JTC plc
21st Jan 202612:12 pmRNSForm 8.3 - Unite Group plc, The
21st Jan 202612:05 pmRNSForm 8.3 - Oxford Biomedica plc
21st Jan 202612:01 pmRNSForm 8.3 - JTC plc
21st Jan 20267:00 amRNSQ4 2025 AUMA and Flows Trading Update
19th Jan 20261:04 pmRNSHolding(s) in Company
19th Jan 202611:59 amRNSForm 8.3 - UNITE Group PLC/The
19th Jan 202611:56 amRNSForm 8.3 - Picton Property Income Limited
19th Jan 202611:48 amRNSForm 8.3 - Oxford Biomedica plc
19th Jan 202611:41 amRNSForm 8.3 - JTC PLC
19th Jan 202611:37 amRNSForm 8.3 - International Personal Finance PLC
19th Jan 202611:34 amRNSForm 8.3 - Empiric Student Property PLC
19th Jan 202611:27 amRNSForm 8.3 - Bluefield Solar Income Fund Limited
16th Jan 20269:43 amRNSForm 8.3 - UNITE Group PLC/The

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.